Skip to main content
Equibles

MENS · Jyong Biotech Ltd.

Track MENS — free

Use MENS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MENS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.74 -0.15 (-7.94%)
Rebalance outlook locked
Market Cap
$143.69M
Shares
76.03M
Volume · Oct 22 130.17K Avg daily vol (3M) 45.16K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.74 Open$1.94 Day$1.64–2.00 52W close$1.46–60.80 Avg vol 30d48K Short int222K · 0.3% float · 4.0d Short vol88% DataJun 2025–Oct 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.0%
Year over year · more shares
Price change (1Y)
-96.9%
Trailing year
Short interest
0.3%
Latest settlement · 4.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bullish Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 16.7 · calm Equity put/call 0.52
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −21%
below
Price vs 50-day avg −17%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −19%
trailing
6-month return −23%
trailing
YTD return −56%
this year
Relative strength −29%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+12% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.29% of float · ▼ -9.5% MoM · 4.0 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
19 holders — near 1-yr high, broad support
Squeeze score 36
low risk · 0–100
Fundamentals
Poor
EPS growth −50%
Y/Y
Balance sheet $16.3M
net debt
Quant / Vol
risk profile
Very High
Volatility 157%
annualized · 1-yr
Max drawdown −98%
past year
ATR 10.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−21% Bearish
Price vs 50-day avg
−17% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+12% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.29% of float · ▼ -9.5% MoM · 4.0 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
19 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $2 · 0% Range high $61
vs 200-day avg -21% vs 50-day avg -17%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MENS
Jyong Biotech Ltd.
this stock
$143.69M -55.9% — — 0.3%
VRTX
Vertex Pharmaceuticals Inc
 $136.14B +18.0% +46.2% 31.3 1.8%
MRNA
Moderna, Inc.
 $98.14B +587.1% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $82.95B +6.1% +20.8% 20.0 2.1%
CSLLY
Csl Ltd
 $66.22B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
19
% held
0.6%
Net QoQ
+34.4K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Falling
Shares short
222.1K
Days to cover
4.0d
Change
-23.2K sh
View
Short Volume
Short vol %
88%
As of
Oct 21, 2026
Short Total
View
Fails to Deliver
FTD shares
414
Value
$840
As of
Sep 30, 2026
View
Off-Exchange
Off-exchange %
49.7%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-4.7M
EPS diluted
$-0.06
View
Filings
SEC Filings
Latest
20-F
Filed
May 15, 2026
This year
3
View

Performance

5D 20D 120D MTD YTD
MENS -12.1% -19.1% -22.7% -15.1% -56.0%
SPY -1.0% -0.4% +6.0% +0.2% +12.0%
vs SPY -11.1% -18.7% -28.7% -15.3% -68.0%
Key facts CIK 1954488 CUSIP G83116106 Visit website